ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A

Pace Elcot Automation

Vysali Pharmaceuticals Vysali Pharmaceuticals, an existing dividend paying company manufacturing a wide nuige of pharmaceutical formulations, is setting up a bulk drugs plant for the manufacture of semi synthetic penicillins, antibiotics and antibacterials in a phased manner, expecting to earn a reasonable profit working at 10 per cent, 30 per cent and 45 per cent of installed capacity in the first, second and third year of operations. The implementation of the first phase will be completed by September 1992 and the entire project by September 1993, The company expects to exploit the vast potential in the domestic and export market for the complete range of injectibte penicillins and have received enquiries already From Nigeria, Ghana, Zaire, and Abu Dhabi. Promoted by A D Krishnan and Savithry Krishnan, both having had 15 years of experience in pharmaceutical companies, the project in Alwaye village, Ernakulam District, Kerala, will source indigenous machinery and process equipment. The project appraisal has been done by Kerala State Industrial Development Corporation, with its cost estimated at Rs 493 lakh. The public issue of 30,00,000 equity shares of Rs 10 each at par, aggregating Rs 300 lakh, opens on July 6.

Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

826for India

$50for overseas users

Get instant access to the complete EPW archives

Subscribe now

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top